This Investor Sold Million: Why Biotech Shares Stay Bullish
A prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Knowing when to switch from passive to active strategies can boost returns. This guide outlines practical signals, costs, and risk considerations.
27,240 articlesA prominent investor dumped a multi‑million stake in a biotech stock that’s up double digits. This article explains w...
Brady Corporation, Pitney Bowes, and CompoSecure report stronger cash flow, expanding margins, and strategic bets in ...
Cleo Capital urges investors to recalibrate Nvidia's growth outlook as AI infrastructure spending moves from explosiv...
Salesforce delivered a solid Q4 beat and announced a $50 billion buyback, but FY27 guidance disappointed investors. T...
Snowflake has slid this year even as its data cloud strategy gains momentum. This guide breaks down whether the pullb...
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
As market conditions shift in 2026, debates over when to claim Social Security intensify. Suze Orman right about dela...
A disciplined, factor-based approach to gold miners may offer resilience as bullion eyes new highs. Here’s how the ET...
A seasoned investor warns that the global financial system faces a new kind of threat: capital shifts driven by debt,...
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
Markets grapple with a hypothetical energy shock after a White House remark suggesting oil could surge to $200 per ba...